FDA approves Medivation (MDVN) XTANDI for Prostate Cancer

August 31, 2012 1:11 PM EDT Send to a Friend
FDA approves Medivation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login